Iodide

Iodide

SCHEMBL1032295

[I-].c1ccc(C[Sn+](Cc2ccccc2)Cc2ccccc2)cc1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CALM1 P0DP23 1/20 0.47
TSHR P16473 4/20 0.43
ALDH1A1 P00352 3/20 0.43
IDO1 P14902 3/20 0.43
LOXL2 Q9Y4K0 2/20 0.43
TP53 P04637 1/20 0.43
TRPA1 O75762 1/20 0.43
MAOB P27338 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41
CASP1 P29466 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TAAR1 Q96RJ0 2/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
TDP1 Q9NUW8 2/20 0.39
CYP2A6 P11509 1/20 0.39
HTR2A P28223 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL7540197 0.94 CALM1 (0.47) CALM1TSHRALDH1A1IDO1LOXL2
Hydrochloric Acid SCHEMBL1030799 0.94 CALM1 (0.47) CALM1TSHRALDH1A1IDO1LOXL2
Fluoride Ion SCHEMBL5897693 0.94 CALM1 (0.47) CALM1TSHRALDH1A1IDO1LOXL2
Bromide SCHEMBL5897988 0.94 CALM1 (0.47) CALM1TSHRALDH1A1IDO1LOXL2
SCHEMBL11787603 0.94 CALM1 (0.47) CALM1TSHRALDH1A1IDO1LOXL2
Hydrochloric Acid SCHEMBL8855132 0.75 CALM1 (0.41) CALM1TSHRALDH1A1IDO1LOXL2
SCHEMBL3747885 0.67
Diphenylmethane SCHEMBL1303 0.65 CALM1 (1.00) CALM1TSHRALDH1A1IDO1LOXL2
Diphenylmethane SCHEMBL3792579 0.65 CALM1 (1.00) CALM1TSHRALDH1A1IDO1LOXL2
SCHEMBL62125 0.65 ALDH1A1 (0.69) CALM1ALDH1A1LOXL2MAOBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7008899-B2 Lanthanide-based catalyst composition for producing cis-1,4-polydienes BRIDGESTONE CORPORATION (JP) 2006-03-07 US claimed
US-20050038215-A1 Lanthanide-based catalyst composition for producing cis-1,4-polydienes BRIDGESTONE CORPORATION (JP) 2005-02-17 US claimed
US-6395912-B1 ISOMERIZATION OF EPOXY COMPOUND EASTMAN CHEMICAL COMPANY 2002-05-28 US claimed
US-6335455-B1 FROM GAMMA, DELTA-EPOXYALKENES EASTMAN CHEMICAL COMPANY 2002-01-01 US claimed
EP-1049688-B1 PROCESS FOR THE PRODUCTION OF 2,5-DIHYDROFURAN EASTMAN CHEM CO (US) 2001-09-12 EP claimed
EP-1049688-A1 PROCESS FOR THE PRODUCTION OF 2,5-DIHYDROFURAN EASTMAN CHEMICAL COMPANY (US) 2000-11-08 EP claimed
WO-1999035137-A1 PROCESS FOR THE PRODUCTION OF 2,5-DIHYDROFURAN EASTMAN CHEMICAL COMPANY (US) 1999-07-15 WO claimed
US-20150080581-A1 MULTICOORDINATED METAL COMPLEXES FOR USE IN METATHESIS REACTIONS RIMTEC CORPORATION (JP) 2015-03-19 US disclosed
US-8927670-B2 Multicoordinated metal complexes for use in metathesis reactions RIMTEC CORPORATION (JP) 2015-01-06 US disclosed
EP-2397475-B1 4, 4' disubstituted 4H-cyclopentadithiophene and new methods for synthesising the same IMEC (BE) 2014-11-12 EP disclosed
US-8765882-B2 Polythiophene based active layer for solar cells IMEC (BE) 2014-07-01 US disclosed
US-8450604-B2 Polymerisable compounds for making opto-electronic devices IMEC (BE) 2013-05-28 US disclosed
US-8329923-B2 4, 4′ disubstituted 4H-cyclopentadithiophene and new methods for synthesizing the same IMEC (BE) 2012-12-11 US disclosed
WO-1994003272-A1 PROCESS FOR THE SEPARATION OF OLIGOMERIC MATERIALS FROM A CATALYST MIXTURE EASTMAN CHEMICAL COMPANY (US) 1994-02-17 WO disclosed
US-5238889-A Solvent extraction EASTMAN KODAK COMPANY (US) 1993-08-24 US disclosed
WO-1993010111-A1 CONTINUOUS PROCESS FOR THE MANUFACTURE OF 2,5-DIHYDROFURANS FROM η,δ-EPOXYBUTENES EASTMAN KODAK COMPANY (US) 1993-05-27 WO disclosed
EP-0518973-A1 ISOMERIZATION OF EPOXYALKENES TO 2,5-DIHYDROFURANS AND CATALYSTS COMPOSITIONS USEFUL THEREFOR. EASTMAN KODAK CO (US) 1992-12-23 EP disclosed
US-5082956-A Quaternary onium iodide catalyst EASTMAN KODAK COMPANY (US) 1992-01-21 US disclosed
WO-1991013882-A1 ISOMERIZATION OF EPOXYALKENES TO 2,5-DIHYDROFURANS AND CATALYSTS COMPOSITIONS USEFUL THEREFOR EASTMAN KODAK COMPANY (US) 1991-09-19 WO disclosed
US-4148814-A Process for preparing monohydrocarbyltin trihalides PENNWALT CORPORATION (US) 1979-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150080581-A1 MULTICOORDINATED METAL COMPLEXES FOR USE IN METATHESIS REACTIONS APEX1, SOD1, AP1M1 CALM1 4108/4885TSHR 4417/4885ALDH1A1 1713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.